Icagen, Inc. New (ICGN) Cash Flow Statement

Click line-items for a historical chart and %

Net loss	-4.69M
Depreciation and amortization of property and equipment	330K
Amortization of technology licenses and related costs	15K
Stock-based compensation	641K
Loss on the disposal of equipment	0
Accounts receivable	620K
Prepaid expenses and other current and non-current assets	-556K
Accounts payable and accrued expenses	265K
Other liabilities	-30K
Deferred revenue	0
Net cash used in operating activities	-3.4M
Acquisition of property and equipment	-45K
Net cash used in investing activities	-45K
Payment of payroll taxes upon vesting of restricted stock	-21K
Proceeds from sale of common stock, net of stock issuance costs	5.49M
Payments on equipment debt financing	-198K
Proceeds from exercise of stock options and warrants	0
Net cash provided by (used in) financing activities	5.27M
Increase (decrease) in cash and cash equivalents	1.82M
Cash and cash equivalents at beginning of period	12.03M
Cash and cash equivalents at end of period	13.86M
Cash paid for interest	30K

Entities mentioned with ICGN

View All Entities